Funder: Novo Nordisk
Due Dates: October 8, 2025 (Stage 1 Expression of Interest) | February 4, 2026 (Stage 2 Full Proposal)
Funding Amounts: DKK 40–75 million (approx. EUR 5.4–10 million) per grant; 6 years; total call budget DKK 150 million (EUR 20 million).
Summary: Supports ambitious, collaborative research consortia to advance understanding and treatment of human invasive fungal diseases.
Key Information: Main applicant must be based at a European/Schengen/UK institution and consortium must include a Danish partner.